Dobutamine Hydrochloride In Dextrose Injection
Product Images NDC 0338-1075

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dobutamine Hydrochloride In Dextrose (NDC 0338-1075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dobutamine Hydrochloride Structural Formula (Image 01)

Chemical structure of Dobutamine Hydrochloride, showing the molecular composition with hydroxyl groups and aromatic rings connected by hydrocarbon chains.*

FDA Label Image

D-glucopyranose Monohydrate (Dextrose Hydrous Structural Formula)

Chemical structure of Dobutamine Hydrochloride, showing its molecular arrangement with multiple hydroxyl groups and an ether linkage. The structure includes a sugar moiety and is depicted with a hydration component (H2O).*

FDA Label Image

Representative Container Label 0338-1073-02 (Image 03)

Label for Dobutamine Hydrochloride in Dextrose Injection, indicating 250 mg per 250 mL (1,000 mcg/mL) concentration. The sterile single-dose container holds 250 mL, with each 100 mL containing 100 mg Dobutamine HCl USP. Includes details on dextrose, sodium bisulfite, pH, osmolality, and storage instructions. Manufactured by Baxter Healthcare Corporation, USA.*

FDA Label Image

Representative Carton Label 0338-1073-02 (Image 04)

Label for Dobutamine 250 mg per 250 mL Injection with Dextrose 5%, showing lot number T123456 and expiration date January 2020. The label includes a barcode and QR code, package quantity of 18-250 mL, and NDC 0338-1073-02. The product is intravenous injection by Baxter Healthcare Corporation.*

FDA Label Image

Dobutamine Hydrochloride Representative Container Label (Image 05)

Label for Dobutamine Hydrochloride in Dextrose Injection showing the proprietary name Dobutamine, with a strength of 500 mg per 250 mL and concentration of 2,000 mcg/mL. The label specifies it as a sterile single-dose container manufactured by Baxter Healthcare Corporation and includes additional formulation details such as sodium bisulfite as stabilizer and instructions for storage.*

FDA Label Image

Representative Carton Label 0338-1075-02 (Image 06)

Label for Dobutamine Hydrochloride in Dextrose 500 mg per 250 mL injection, Dextrose 5%, showing lot number, expiration date January 2020, and NDC 0338-1075-02. Label includes barcode and QR code, quantity 18-250 mL, and manufacturer Baxter Healthcare Corporation.*

FDA Label Image

Representative Container Label Ndc 0338-1077-02 (Image 07)

Label for Dobutamine Hydrochloride in Dextrose Injection by Baxter Healthcare Corporation. The concentration is 4,000 mcg/mL (1,000 mg per 250 mL) in a sterile single dose container. The label includes preparation details such as equivalent contents of Dobutamine HCl and Dextrose Hydrous, pH range, osmolarity, storage instructions, and a note that the product is RX only.*

FDA Label Image

Representative Carton Label 0338-1077-02 (Image 08)

Label for Dobutamine Hydrochloride Injection, 1000 mg per 250 mL in 5% Dextrose solution, from Baxter Healthcare Corporation. The label includes lot number T123456, expiration date January 2020, NDC 0338-1077-02, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.